01 Aug, EOD - Indian

Nifty Smallcap 100 17668.2 (-1.66)

Nifty Pharma 22011.7 (-3.33)

Nifty 50 24565.35 (-0.82)

Nifty IT 34649.6 (-1.85)

Nifty Midcap 100 56637.15 (-1.33)

SENSEX 80599.91 (-0.72)

Nifty Bank 55617.6 (-0.62)

Nifty Next 50 66192.8 (-1.35)

01 Aug, EOD - Global

NIKKEI 225 40799.6 (-0.66)

HANG SENG 24507.81 (-1.07)

S&P 6275.25 (-1.74)


Mid Session News

You are Here : Home > News > Mid Session News >

(31 Jul 2025, 12:31)

Nifty below 24,850; realty shares decline


The domestic equity benchmarks traded with small cuts in early afternoon trade. The Nifty traded below the 24,850 mark. Realty shares extended losses for the second consecutive trading session.

At 12:30 IST, the barometer index, the S&P BSE Sensex, declined 75.34 points or 0.09% to 81,406.52. The Nifty 50 index lost 23.20 points or 0.10% to 24,833.35.

The broader market underperformed the frontline indices. The S&P BSE Mid-Cap index slipped 0.58% and the S&P BSE Small-Cap index fell 0.36%.

The market breadth was weak. On the BSE, 1,494 shares rose and 2,270 shares fell. A total of 190 shares were unchanged.

Derivatives:

The NSE's India VIX, a gauge of the market's expectation of volatility over the near term, rose 4.30% to 11.69. The Nifty 31 July 2025 futures were trading at 24,935.60, at a premium of 102.25 points as compared with the spot at 24,833.35.

The Nifty option chain for the 31 July 2025 expiry showed a maximum call OI of 181.1 lakh contracts at the 25,000 strike price. Maximum put OI of 267.3 lakh contracts was seen at 24,700 strike price.

Buzzing Index:

The Nifty Realty index fell 1.06% to 907.95. The index dropped 2% in two consecutive trading sessions.

Oberoi Realty (down 1.81%), Anant Raj (down 1.7%), Prestige Estates Projects (down 1.53%), Phoenix Mills (down 1.41%), Raymond (down 1.4%), Brigade Enterprises (down 1%), Godrej Properties (down 0.94%), Sobha (down 0.89%), DLF (down 0.49%) and Lodha Developers (down 0.3%) declined.

Stocks in Spotlight:

Mahindra & Mahindra rose 0.41%. The company’ standalone net profit surged 32% to Rs 3,449.84 crore in Q1 FY26 as against Rs 2,612.63 crore recorded in Q1 FY25. Revenue from operations increased 26.1% year on year (YoY) to Rs 34,083.23 crore in the quarter ended 30 June 2025.

JB Chemicals & Pharmaceuticals fell 1.67%. The company reported consolidated net profit surged 14.45% to Rs 202.38 crore on an 8.91% jump in revenue from operations to Rs 1,093.94 crore in Q1 FY26 over Q1 FY25.

More News

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +